MENODYS’s Tinnitus Assessment Technology featured in medGadget’s Ear, Nose and Throat Diagnostic and Surgical Devices Pipeline Review, 2015

Longueuil, Quebec, Canada – MENODYS and its Tinnitus Assessment Technology are featured in the Ear, Nose and Throat Diagnostic and Surgical Devices Pipeline Review, 2015 of medGadget, the web-based medical technology news source, dated September 18th 2015. Exclusively licenced to MENODYS and invented by Pr Sylvie Hébert and Philippe Fournier of the School of Speech Pathology and Audiology of the University of Montreal, the Tinnitus Assessment Technology offers audiology specialists around the world a faster and objective approach to assess the frequency spectrum and amplitude of their patient’s tinnitus. This medical technology will thus allow audiology specialists to better design the symptoms attenuation protocol of the patient’s tinnitus.

“Being part of such international market research studies is a confirmation of our business model of bringing innovative medical technology ideas to the market and for international medical device companies to take on their commercialization. We have recently completed the development and validation of the technology and we have initiated discussions with possible commercialization partners with the hope of quickly bringing this innovative approach in audiology to the growing worldwide population suffering from tinnitus”, said Richard Côté, Executive Vice President of MENODYS.

Tinnitus is an important health issue in audiology affecting more than 360 000 Canadians, 30 million Americans and more than 120 million Europeans.

MENODYS is a Canadian company specialized in the development and commercialization of medical technologies.